Direct Economic Burden of Dry Eye Disease Patients in Central China, 2018-2019

A health economics study of 221 Chinese adults with dry eye disease (DED) treated at Wuhan Aier Hankou Eye Hospital. Data on examination, pharmacological, and nonpharmacological therapy costs were collected via an outpatient medical record system from January 2018 to August 2018, with at least one year of follow-up. The research was authored by Yanzhu Luo and published via an Open Access (green) license.

Use Cases

• Regression analysis of healthcare costs based on patient age and sex mentioned in the description
• Identifying cost-influencing factors based on disease severity and subtype (mixed and evaporative dry eye)
• Modeling annual direct economic burden based on the number of hospital visits
• Comparative cost analysis between demographic groups, such as females aged 40-49 versus males

Strengths

• Includes a specific cohort of 221 patients with at least one year of follow-up.
• Reports a precise average annual direct economic burden of $465.54 ± $303.08 per patient.
• Identifies specific influencing factors (age, hospital visits, severity, subtype) through regression analysis.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic bias inherent to a single hospital in Central China.

Provenance

Source

Yanzhu Luo

Collection Method

Costs collected through the outpatient medical record system of Wuhan Aier Hankou Eye Hospital.

Time Range

January 2018 to at least August 2019 (enrollment Jan-Aug 2018, follow-up ≥1 year).

Geography

Central China (specifically Wuhan, Hubei province).